AGF US Market Neutral Anti-Beta Fund
BTAL
5 hedge funds and large institutions have $366K invested in AGF US Market Neutral Anti-Beta Fund in 2013 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 5 → 5 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
6.37% less ownership
Funds ownership: 19.16% → 12.79% (-6.4%)
51% less capital invested
Capital invested by funds: $748K → $366K (-$382K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citigroup
New York
|
+$17.6K |
| 2 |
CG
Colony Group
Boston,
Massachusetts
|
+$4.77K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VKH
Virtu KCG Holdings
New York
|
-$391K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$4K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
VKH
1
Virtu KCG Holdings
New York
| $250K | -$391K | -20,088 | -60% |
|
|
2
Citigroup
New York
| $83K | +$17.6K | +906 | +27% |
|
|
U
3
UBS
Zurich,
Switzerland
| $24K | – | – | – |
|
|
CG
4
Colony Group
Boston,
Massachusetts
| $5K | +$4.77K | +245 | New |
|
5
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $4K | – | – | – |
|
|
TRCT
6
Tower Research Capital (TRC)
New York
| – | -$4K | -200 | Closed |
|
BTAL Hedge Fund Activity: Q4 2013 in Review
5 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in AGF US Market Neutral Anti-Beta Fund (BTAL) for Q4 2013, worth a combined $366K — down 51% from $748K a quarter earlier.
Fund positioning in BTAL was balanced in Q4 2013: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was Citigroup, adding an estimated $17.6K. The largest seller was Virtu KCG Holdings, cutting an estimated $391K.
- 5 institutional investors held AGF US Market Neutral Anti-Beta Fund (BTAL) as of Q4 2013, unchanged from Q3 2013.
- Funds reported $366K of AGF US Market Neutral Anti-Beta Fund stock for Q4 2013, down 51% quarter-over-quarter.
- 1 fund opened new AGF US Market Neutral Anti-Beta Fund positions in Q4 2013 and 1 closed out, a net change of 0 holders.
- The largest AGF US Market Neutral Anti-Beta Fund buyer in Q4 2013 was Citigroup, an estimated $17.6K added.
- The largest AGF US Market Neutral Anti-Beta Fund seller in Q4 2013 was Virtu KCG Holdings, an estimated $391K sold.
Based on aggregated 13F filings for Q4 2013.